Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

  1. Home
  2. NLST
  3. Publications

NLST Publications

Here you can browse the complete list of publications for NLST

Studies
Publication Year
Reset

Results: 140 (Showing 41 to 60) — Export these results

Title PubMed Id Authors Journal Abbreviation Year Studies
The Relations between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Cancer Screening Trial: Implications for Public Health. 25746779 Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF Nicotine Tob. Res. 2015 NLST
Bayesian Estimation of the Three Key Parameters in CT for the National Lung Screening Trial Data Ruiqi Liu, Beth Levitt, Tom Riley, Dongfeng Wu J Biom Biostat 2015 NLST
Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. 26712960 Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER Oncologist 2015 NLST
Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. 25759972 Chiles C, Duan F, Gladish GW, Ravenel JG, Baginski SG, Snyder BS, DeMello S, Desjardins SS, Munden RF, For of the NLST Study Team Radiology 2015 NLST
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. 25863905 Wilson DO, Weissfeld J Lung Cancer 2015 NLST
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. 26238115 Gohagan JK, Prorok PC, Greenwald P, Kramer BS Rev Recent Clin Trials 2015 NLST, PLCO
Computed Tomography Screening for Lung Cancer in the National Lung Screening Trial: A Cost-effectiveness Analysis. 25635704 Black WC J Thorac Imaging 2015 NLST
Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. 26372542 Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ Cancer 2015 NLST
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment. 25664444 Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E Ann. Intern. Med. 2015 NLST
The Association Between Smoking Abstinence and Mortality in the National Lung Screening Trial. 26502000 Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Hughes Halbert C, Warren GW, Egede LE, Silvestri GA Am. J. Respir. Crit. Care Med. 2015 NLST
Factor Structure and Stability of Smoking-Related Health Beliefs in the National Lung Screening Trial. 25964503 Kaufman AR, Koblitz AR, Persoskie A, Ferrer RA, Klein WM, Dwyer LA, Park ER Nicotine Tob. Res. 2015 NLST
Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare. 25943596 Roth JA, Sullivan SD, Goulart BH, Ravelo A, Sanderson JC, Ramsey SD J Oncol Pract 2015 NLST
Data-Driven Decision Support for Radiologists: Re-using the National Lung Screening Trial Dataset for Pulmonary Nodule Management. 24965276 Morrison JJ, Hostetter J, Wang K, Siegel EL J Digit Imaging 2015 NLST
A Query Tool for Investigator Access to the Data and Images of the National Lung Screening Trial. 25739345 Commean PK, Rathmell JM, Clark KW, Maffitt DR, Prior FW J Digit Imaging 2015 NLST
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. 26602092 Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V Urol. Oncol. 2015 NLST, PLCO
Cost-effectiveness of Lung Cancer Screening in Canada. 26226181 Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK JAMA Oncol 2015 NLST
Visual scoring of coronary artery calcification in lung cancer screening computed tomography: association with all-cause and cardiovascular mortality risk. 25370000 Watts JR, Sonavane SK, Snell-Bergeon J, Nath H Coron. Artery Dis. 2015 NLST
Noninvasive CT-Based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. 26052977 Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, Peikert T Am. J. Respir. Crit. Care Med. 2015 NLST
Racial Differences in Outcomes within the National Lung Screening Trial: Implications for Widespread Implementation. 25928649 Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA Am. J. Respir. Crit. Care Med. 2015 NLST
Performance of the cancer risk management model lung cancer screening module. 25993046 Flanagan WM, Evans WK, Fitzgerald NR, Goffin JR, Miller AB, Wolfson MC Health Rep 2015 NLST